| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 42.03B | 42.69B | 43.38B | 37.62B | 35.47B | 36.27B |
| Gross Profit | 10.28B | 10.31B | 10.78B | 9.20B | 8.61B | 8.23B |
| EBITDA | 2.28B | 2.72B | 3.30B | 2.21B | 1.90B | 1.50B |
| Net Income | 1.36B | 1.68B | 1.84B | 996.36M | 1.23B | -452.45M |
Balance Sheet | ||||||
| Total Assets | 26.25B | 27.41B | 28.42B | 26.19B | 24.67B | 24.31B |
| Cash, Cash Equivalents and Short-Term Investments | 11.52B | 10.46B | 10.05B | 7.29B | 7.53B | 6.42B |
| Total Debt | 2.25B | 2.36B | 2.39B | 2.65B | 3.13B | 3.93B |
| Total Liabilities | 14.01B | 14.69B | 16.69B | 16.29B | 15.53B | 16.13B |
| Stockholders Equity | 12.18B | 12.67B | 11.68B | 9.86B | 9.11B | 8.14B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.28B | 4.02B | 504.81M | 2.25B | 818.48M |
| Operating Cash Flow | 0.00 | 1.32B | 4.13B | 556.15M | 2.27B | 1.08B |
| Investing Cash Flow | 0.00 | -71.25M | -543.46M | 366.40M | -78.33M | -63.87M |
| Financing Cash Flow | 0.00 | -830.97M | -826.11M | -1.11B | -1.09B | -108.93M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥193.10B | 4.98 | 17.09% | 2.94% | 9.67% | 45.58% | |
76 Outperform | ¥22.45B | 10.49 | ― | 3.83% | 41.87% | 167.99% | |
74 Outperform | ¥49.95B | 13.51 | ― | 4.12% | -4.88% | -26.05% | |
72 Outperform | ¥14.66B | 25.64 | ― | 4.62% | -2.98% | 4.56% | |
65 Neutral | ¥29.30B | -17.27 | ― | 5.16% | 1.71% | -29.37% | |
64 Neutral | ¥32.49B | 40.99 | 1.55% | 1.34% | -34.13% | -31.24% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |